Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas
Bone Marrow Transplant
.
2021 Sep;56(9):2295-2298.
doi: 10.1038/s41409-021-01359-x.
Epub 2021 Jun 9.
Authors
Francesca Bonifazi
1
,
Irene Defrancesco
2
3
,
Jacopo Olivieri
4
,
Francesco Barbato
5
,
Paolo Lopedote
5
,
Michele Dicataldo
5
,
Mariarosaria Sessa
6
,
Elisa Dan
7
,
Barbara Sinigaglia
7
,
Luca Zazzeroni
7
,
Simonetta Rizzi
7
,
Cristina Tassi
7
,
Beatrice Casadei
7
5
,
Pier Luigi Zinzani
7
5
,
Mario Arpinati
7
Affiliations
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna; Istituto "L. e A. Seràgnoli", Bologna, Italy.
[email protected]
.
2
Department of Medical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
3
Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
4
Clinica Ematologica, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
5
Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
6
Hematology Section, Department of Medical Sciences, Azienda Ospedaliero-Universitaria, Arcispedale S. Anna, University of Ferrara, Ferrara, Italy.
7
IRCCS Azienda Ospedaliero-Universitaria di Bologna; Istituto "L. e A. Seràgnoli", Bologna, Italy.
PMID:
34108674
DOI:
10.1038/s41409-021-01359-x
No abstract available
Publication types
Letter
MeSH terms
Graft vs Host Disease* / prevention & control
Hematopoietic Stem Cell Transplantation*
Humans
Lymphoma* / therapy